{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:34:58Z","timestamp":1791221698412,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/mbc.0b013e3282f2b5d9","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T03:06:54Z","timestamp":1206587214000},"page":"203-207","source":"Crossref","is-referenced-by-count":33,"title":["Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease"],"prefix":"10.1097","volume":"19","author":[{"given":"Edward","family":"Peres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Kintzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Baynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneer","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami B","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Abella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","first-page":"285","article-title":"Veno-occlusive disease of the liver with nonportal type of cirrhosis occurring in Jamaica","volume":"57","author":"Bras","year":"1954","journal-title":"Arch Pathol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Veno-occlusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","article-title":"Changes in hemostatic parameters in hepatic veno-occluisve disease following bone marrow transplantation","volume":"19","author":"Park","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1040578","article-title":"Liver disease after human marrow transplantation","volume":"7","author":"McDonald","year":"1987","journal-title":"Semin Liver Dis"},{"key":"R8-4-20210203","first-page":"10","article-title":"Chemistry of the haemostatic mechanism and its relationship to the action of heparin","volume":"36","author":"Rosenberg","year":"1977","journal-title":"Fed Proc"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"key":"R11-4-20210203","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplanation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-4-20210203","first-page":"1729","article-title":"Venoocclusive disease of the liver: development of a model for predicting fatal outcomes after marrow transplantation","volume":"11","author":"Bearman","year":"1993","journal-title":"Anal Clin Oncol"},{"key":"R15-4-20210203","first-page":"443","article-title":"Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion AT-III concentrate","volume":"17","author":"Patton","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-198907000-00016","article-title":"Predictabilty before transplant of hepatic complications following allogeneic bone marrow transplantation","volume":"48","author":"Locasciulli","year":"1989","journal-title":"Transplantation"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(80)90368-X","article-title":"Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation, and bone marrow transplantation","volume":"68","author":"Woods","year":"1980","journal-title":"Am J Med"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","article-title":"Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center","volume":"26","author":"Tanikawa","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/BF02088576","article-title":"Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reprefusion of rat liver","volume":"41","author":"Hisama","year":"1996","journal-title":"Dig Dis Sci"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00007890-199902270-00006","article-title":"Antithrombin III treatment improves parameters of acute inflammation in a highly histocompatible model of rat lung allograft rejection","volume":"67","author":"Okada","year":"1999","journal-title":"Transplantation"},{"key":"R21-4-20210203","first-page":"79","article-title":"Early treatment with AT III in acute liver failure","volume":"73","author":"Vogel","year":"1983","journal-title":"Behring InstMitt"},{"key":"R22-4-20210203","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with venoocclusive disease (VOD): a retrospective multicentre study demonstrating superior therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200804000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:54:05Z","timestamp":1786035245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200804000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3282f2b5d9","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}